Synthesis of microporous silica nanoparticles as a versatile nanocarrier for 5-fluorouracil delivery in colon cancer chemotherapy
Bibliographic record
Abstract
No abstract is available for this record. The assistant can identify its topic from the title, but cannot infer the study’s results.
Source: Not provided · Quality: missing
Research context
OpenAlex topics: Nanoparticle-Based Drug Delivery · Mesoporous Materials and Catalysis · Colorectal Cancer Treatments and Studies
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (34)
Show source-provided references
1. Xi Y, Xu P (2021) Global colorectal cancer burden in 2020 and projections to 2040. Transl Oncol 14:10117410.1016/j.tranon.2021.101174 ↗
2. Rawla P, Sunkara T, Barsouk A (2019) Epidemiology of colorectal cancer: incidence, mortality, survival, and risk factors. Prz Gastroenterol 14:89–103
3. Xie Y, Chen Y, Fang J (2020) Comprehensive review of targeted therapy for colorectal cancer. Signal Transduction Targeted Ther 5:1–3010.1038/s41392-020-0116-z ↗
4. Marcelo GA, Montpeyó D, Galhano J, Martínez-Máñez R, Capelo-Martínez JL, Lorenzo J, Lodeiro C, Oliveira E (2023) Development of new targeted nanotherapy combined with magneto-fluorescent nanoparticles against colorectal cancer. Int J Mol Sci 24:661210.3390/ijms24076612 ↗
5. Vodenkova S, Buchler T, Cervena K, Veskrnova V, Vodicka P, Vymetalkova V (2020) 5-fluorouracil and other fluoropyrimidines in colorectal cancer: past, present and future. Pharmacol Ther 206:10744710.1016/j.pharmthera.2019.107447 ↗
6. Liszbinski RB, Romagnoli GG, Gorgulho CM, Basso CR, Pedrosa VA, Kaneno R (2020) Anti-EGFR-coated gold nanoparticles in vitro carry 5-fluorouracil to colorectal cancer cells. Materials 13:37510.3390/ma13020375 ↗
7. Housman G, Byler S, Heerboth S, Lapinska K, Longacre M, Snyder N, Sarkar S (2014) Drug resistance in cancer: an overview. Cancers 6(3):1769–179210.3390/cancers6031769 ↗
8. Ma S-C, Zhang J-Q, Yan T-H, Miao M-X, Cao Y-M, Cao Y-B, Zhang L-C, Li L (2023) Novel strategies to reverse chemoresistance in colorectal cancer. Cancer Med 12:11073–1109610.1002/cam4.5594 ↗
9. Cheng Y-H, He C, Riviere JE, Monteiro-Riviere NA, Lin Z (2020) Meta-analysis of nanoparticle delivery to tumors using a physiologically based pharmacokinetic modeling and simulation approach. ACS Nano 14:3075–309510.1021/acsnano.9b08142 ↗
10. Narayana S, Gowda BHJ, Hani U, Shimu SS, Paul K, Das A, Ashique S, Ahmed MG, Tarighat MA, Abdi G (2024) Inorganic nanoparticle-based treatment approaches for colorectal cancer: recent advancements and challenges. J Nanobiotech 22:42710.1186/s12951-024-02701-3 ↗
11. Wang CY, Li D, Chen X, Chen Z (2024) Facile fabrication of anticancer peptide coated zeolite imidazole framework for effective treatment of colorectal cancer cells and its apoptosis induction. Process Biochem 143:34–4310.1016/j.procbio.2024.03.007 ↗
12. Dezfuli AAZ, Abu-Elghait M, Salem SS (2024) Recent insights into nanotechnology in colorectal cancer. Applied Biochem Biotech 196(7):4457–447110.1007/s12010-023-04696-3 ↗
13. Zhang W, Taheri-Ledari R, Ganjali F, Mirmohammadi SS, Qazi FS, Saeidirad M, KashtiAray A, Zarei-Shokat S, Tianc Y, Maleki A (2023) Effects of morphology and size of nanoscale drug carriers on cellular uptake and internalization process: a review. RSC Adv 13:80–11410.1039/D2RA06888E ↗
14. Liang C, Shi L, Chen Z, Zhou L, Zhang Z, Zhang G (2024) Construction and properties of venlafaxine hydrochloride sustained release system based on hollow mesoporous silica microspheres. Particuology 86:205–21010.1016/j.partic.2023.06.011 ↗
15. Wu D, Zou J, Chen J, Li Y, Ma N, Dai W (2024) Boosted sustained-release with iron-based MOF-derived mesoporous-carbon-spheres as a nitroimidazole drugs carrier. Particuology 86:269–28010.1016/j.partic.2023.07.003 ↗
16. Xu JJ, Zhang WC, Guo YW, Chen XY, Zhang YN (2022) Metal nanoparticles as a promising technology in targeted cancer treatment. Drug Deliv 29:664–67810.1080/10717544.2022.2039804 ↗
17. Paduraru DN, Ion D, Niculescu AG, Mus F, Andronic O, Grumezescu AM, Bolocan A (2022) Recent developments in metallic nanomaterials for cancer therapy, diagnosing and imaging applications. Pharmaceutics 14:43510.3390/pharmaceutics14020435 ↗
18. Viswanath B, Kim S, Lee K (2016) Recent insights into nanotechnology development for detection and treatment of colorectal cancer. Int J Nanomed 11:2491–2504
19. Hickey AJ (2020) Emerging trends in inhaled drug delivery. Adv Drug Deliv Rev 157:63–7010.1016/j.addr.2020.07.006 ↗
20. Barani M, Bilal M, Rahdar A, Arshad R, Kumar A, Hamishekar H, Kyzas GZ (2021) Nanodiagnosis and nanotreatment of colorectal cancer: an overview. J Nanopart Res 23:1810.1007/s11051-020-05129-6 ↗
21. Pavitra E, Dariya B, Srivani G, Kang S-M, Alam A, Sudhir P-R, Kamal MA, Raju GSR, Han Y-K, Lakkakula BVKS, Nagaraju GP, Huh YS (2021) Engineered nanoparticles for imaging and drug delivery in colorectal cancer. Semin Cancer Biol 69:293–30610.1016/j.semcancer.2019.06.017 ↗
22. Wang L, Sun Q, Wang X, Wen T, Yin J-J, Wang P, Bai R, Zhang X-Q, Zhang L-H, Lu A-H, Chen C (2015) Using hollow carbon nanospheres as a light-induced free radical generator to overcome chemotherapy resistance. J Am Chem Soc 137:1947–195510.1021/ja511560b ↗
23. Chen L, She X, Wang T, He L, Shigdar S, Duan W, Kong L (2015) Overcoming acquired drug resistance in colorectal cancer cells by targeted delivery of 5-FU with EGF grafted hollow mesoporous silica nanoparticles. Nanoscale 7:14080–1409210.1039/C5NR03527A ↗
24. Dhingra S, Goyal S, Thirumal D, Sharma P, Kaur G, Mittal N (2024) Mesoporous silica nanoparticles: a versatile carrier platform in lung cancer management. Nanomedicine 19:1331–134610.1080/17435889.2024.2348438 ↗
25. Liu J, Zhu C, Xu L, Wang D, Liu W, Zhang K, Zhang Z, Shi J (2020) Nanoenabled intracellular calcium bursting for safe and efficient reversal of drug resistance in tumor cells. Nano Lett 20:8102–811110.1021/acs.nanolett.0c03042 ↗
26. Xi J, An L, Huang Y, Jiang J, Wang Y, Wei G, Xu Z, Fan L, Gao L (2021) Ultrasmall FeS2 nanoparticles-decorated carbon spheres with laser-mediated ferrous ion release for antibacterial therapy. Small 17:200547310.1002/smll.202005473 ↗
27. Vallet-Regí M, Schüth F, Lozano D, Colilla M, Manzano M (2022) Engineering mesoporous silica nanoparticles for drug delivery: where are we after two decades? Chem Soc Rev 51:5365–545110.1039/D1CS00659B ↗
28. Chen R, Huang Y, Wang L, Zhou J, Tan Y, Peng C, Yang P, Peng W, Li J, Gu Q, Sheng Y, Wang Y, Shao G, Zhang Q, Sun Y (2021) Cetuximab functionalization strategy for combining active targeting and antimigration capacities of a hybrid composite nanoplatform applied to deliver 5-fluorouracil: toward colorectal cancer treatment. Biomater Sci 9:2279–229410.1039/D0BM01904F ↗
29. Beňová E, Bergé-Lefranc D, Zeleňák V, Almái M, Huntoová V, Hornebecq V (2020) Adsorption properties, the pH-sensitive release of 5-fluorouracil and cytotoxicity studies of mesoporous silica drug delivery matrix. Appl Surf Sci 504:14402810.1016/j.apsusc.2019.144028 ↗
30. Id L, Zeleňák V, Berkutova A, Szcsová J, Zeleňáková A (2020) Nanocargo-delivery platform for targeted drug delivery in biomedical applications: magnetic Gd2O3 nanoparticles in porous SiO2. Acta Phys Pol A 137:773–77510.12693/APhysPolA.137.773 ↗
31. Zhang W-J, Babu A, Yan Y-Z, Park SS, Jo N-J, Chung I, Ahn S-K, Park I-K, Ha C-S (2023) ROS/GSH dual-responsive selenium-containing mesoporous silica nanoparticles for drug delivery. J Porous Mat 30:1469–214810.1007/s10934-023-01430-6 ↗
32. Zhao S-N, Tang R-H, Deng S-J, Chen G-E, Ye J, Xu Z-L (2023) Dual gatekeepers-modified dendritic mesoporous silica nanoparticles for controlled drug release. J Mater Sci 58:17610–1762210.1007/s10853-023-09128-5 ↗
33. Park K, Park SS, Yun YH, Ha C-S (2017) Mesoporous silica nanoparticles functionalized with a redox responsive biopolymer. J Porous Mat 24:1215–122510.1007/s10934-017-0361-x ↗
34. Stöber W, Fink A, Bohn E (1968) Controlled growth of monodisperse silica spheres in the microsize range. J Colloid Interface Sci 26:62–6910.1016/0021-9797(68)90272-5 ↗